Delenex Therapeutics None
Delenex Therapeutics AG is a Swiss biotech company that develops therapeutic antibody fragments to treat serious medical diseases with high unmet needs. The company's fragments are designed for local/topical application using the benefits of antibody therapy with limited systemic exposure. Delenex's technology delivers antibodies with high affinity, solubility, and stability, combined with a low risk of immunogenicity.
